title: Chemokine receptor 5 (CCR5) polymorphism in chronic hepatitis B patients treated with three different nucleos(t)ide analogues.
authors.forename: Varun
authors.initials: V
authors.lastname: Goel
authors.forename: Purabi Deka
authors.initials: PD
authors.lastname: Bose
authors.forename: Manash P
authors.initials: MP
authors.lastname: Sarma
authors.forename: Rajib K
authors.initials: RK
authors.lastname: Hazam
authors.forename: Bhudev C
authors.initials: BC
authors.lastname: Das
authors.forename: Ranjana
authors.initials: R
authors.lastname: Gondal
authors.forename: Premashis
authors.initials: P
authors.lastname: Kar
mesh_terms: D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000410:Alanine Transaminase / Q000378:metabolism; D005838:Genotype; D006514:Hepatitis B Surface Antigens / Q000378:metabolism; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000235:genetics*; D006720:Homozygote; D006801:Humans; D007194:India; D019259:Lamivudine / Q000008:administration & dosage; D008111:Liver Function Tests; D009154:Mutation; D009705:Nucleosides / Q000008:administration & dosage; D009711:Nucleotides / Q000008:administration & dosage; D063065:Organophosphonates / Q000008:administration & dosage; D010865:Pilot Projects; D011110:Polymorphism, Genetic; D019713:Receptors, CCR5 / Q000235:genetics*; D000077712:Telbivudine; D013936:Thymidine / Q000008:administration & dosage / Q000031:analogs & derivatives
chemical_list: C584933:CCR5 protein, human; D006514:Hepatitis B Surface Antigens; D009705:Nucleosides; D009711:Nucleotides; D063065:Organophosphonates; D019713:Receptors, CCR5; D000077712:Telbivudine; D019259:Lamivudine; C053001:adefovir; D000410:Alanine Transaminase; D000225:Adenine; D013936:Thymidine